Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD55 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement CD55 dans FACS et IP. Il présente une réactivité envers Humain.
N° du produit ABIN1106464

Aperçu rapide pour CD55 anticorps (ABIN1106464)

Antigène

Voir toutes CD55 Anticorps
CD55 (Complement Decay-Accelerating Factor (CD55))

Reactivité

  • 135
  • 33
  • 7
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
Humain

Hôte

  • 96
  • 65
  • 6
  • 5
  • 3
  • 1
  • 1
  • 1
Souris

Clonalité

  • 114
  • 62
  • 2
Monoclonal

Conjugué

  • 81
  • 18
  • 16
  • 13
  • 6
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD55 est non-conjugé

Application

  • 102
  • 94
  • 41
  • 36
  • 36
  • 23
  • 17
  • 14
  • 14
  • 14
  • 14
  • 4
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunoprecipitation (IP)

Clone

2C6
  • Réactivité croisée (Details)

    Species reactivity (tested):Human

    Purification

    Protein A agarose

    Immunogène

    Human adenocarcinoma cell line (PC3)

    Isotype

    IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    PBS containing 50 % glycerol, pH 7.2. No preservative is contained.

    Agent conservateur

    Without preservative

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène

    CD55 (Complement Decay-Accelerating Factor (CD55))

    Autre désignation

    CD55 / DAF

    Sujet

    CD55, also known as decay-accelerating factor (DAF), is a GPI-anchored membrane inhibitor of complement. It inhibits complement activation by interfering with the function of C3 and C5 convertases in both the classical and alternative pathways. CD55 is expressed on most cells to protect them from complement-mediated attack. CD55 and other membrane complement regulatory proteins (CD46 and CD59) are frequently overexpressed on cancer cells, possibly as a mechanism for cancer cells to overcome lysis by complement. Virus-receptor interactions have been elucidated for several viruses that use CD55 as an adhesion or invasion receptor, including enterovirus, echovirus, and coxsackie B virus. Moreover, CD55 also interacts with an epidermal growth factor-seven-span transmembrane (EGF-TM7) receptor, CD97. CD97 antigen becomes immediately up-regulated on most leukocytes during activation and is constitutively expressed by macrophages, dendritic cells, and some epithelial tumors.Synonyms: Complement decay-accelerating factor

    ID gène

    9606

    UniProt

    P08174

    Pathways

    Système du Complément, Regulation of Leukocyte Mediated Immunity
Vous êtes ici:
Chat with us!